|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-1-27
|
|
pubmed:abstractText |
The role for high-dose therapy and autologous stem-cell transplantation in mantle-cell lymphoma (MCL) is unknown. We retrospectively analyzed patients with chemosensitive disease who underwent high-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation (ABMT) for MCL in first remission, as well as following relapse from conventional therapy.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AndersenNN,
pubmed-author:AndersonK CKC,
pubmed-author:AsterJJ,
pubmed-author:FisherD CDC,
pubmed-author:FreedmanA SAS,
pubmed-author:GribbenJ GJG,
pubmed-author:KroonMM,
pubmed-author:MauchPP,
pubmed-author:NadlerL MLM,
pubmed-author:NeubergDD,
pubmed-author:RitzJJ,
pubmed-author:SchlossmanRR,
pubmed-author:SoifferR JRJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9440717-Adult,
pubmed-meshheading:9440717-Aged,
pubmed-meshheading:9440717-Antibodies, Monoclonal,
pubmed-meshheading:9440717-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9440717-B-Lymphocytes,
pubmed-meshheading:9440717-Bone Marrow Purging,
pubmed-meshheading:9440717-Bone Marrow Transplantation,
pubmed-meshheading:9440717-Combined Modality Therapy,
pubmed-meshheading:9440717-Cyclophosphamide,
pubmed-meshheading:9440717-Doxorubicin,
pubmed-meshheading:9440717-Female,
pubmed-meshheading:9440717-Humans,
pubmed-meshheading:9440717-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9440717-Male,
pubmed-meshheading:9440717-Middle Aged,
pubmed-meshheading:9440717-Prednisone,
pubmed-meshheading:9440717-Prognosis,
pubmed-meshheading:9440717-Retrospective Studies,
pubmed-meshheading:9440717-Transplantation, Autologous,
pubmed-meshheading:9440717-Treatment Outcome,
pubmed-meshheading:9440717-Vincristine
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
|
|
pubmed:affiliation |
Division of Hematologic Malignancies and Biostatistics, Dana-Farber Cancer Institute, Boston, MA 02115, USA. arney-freedman@dfci.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
